A new study has found that a molecule thousands of times smaller than a gene is able to kill medulloblastoma, the most common childhood brain cancer.
Four projects promoting the fight against cancer at UT Health San Antonio received a multimillion dollar boost.
The road to survival and the journey of discovery intersect to forge one of the greatest successes in scientific research—a cure for hepatitis C.
A new tool is urgently needed to find a better treatment for pancreatic cancer. One researcher believes he has found one that provides a truer picture of the disease and how it affects humans.
Bladder cancer patients who received the chemotherapy drug gemcitabine had significantly lower recurrence of their cancer, a clinical trial has revealed.
Scientists at UT Health San Antonio and UTHealth in Houston were awarded millions in grants to expand studies of a therapeutic antibody to stem the spread of breast cancer to the bone.
UT Health San Antonio has garnered highly competitive National Institutes of Health grants to speed the translation of research discovery into improved patient care.
The Cancer Prevention & Research Institute of Texas awarded $6 million to UT Health San Antonio to support the recruitment of an internationally known biochemist.
In January, Peggy and Lowry Mays announced an increase in their legacy gift to $30 million to support UT Health San Antonio’s cancer center, which recently affiliated with MD Anderson Cancer Center.
The air we breathe proved almost fatal for one boy struggling to survive childhood leukemia.